Artha Sootra - Company Dashboard

Governance Classic Home

Solara Active Pharma Sciences LtdPharmaceuticalsINE624Z01016Consolidated₹645.40+16.15 (+2.57%)

Valuation

Market Cap₹3.11K Cr

TTM PE84.30x

Forward PE41.60x

PEG-0.06

Book Value₹298.12

P/B2.16x

TTM EPS₹7.65

Fwd EPS₹15.50

TTM Revenue₹1.54K Cr

TTM PAT₹36.94 Cr

TTM EBITDA₹233.81 Cr

TTM EBIT₹128.85 Cr

Last Qtr PAT₹28.46 Cr

Last Qtr EBITDA₹76.84 Cr

Last Qtr EBIT₹50.20 Cr

Profitability

ROE2.57%

ROCE7.09%

TTM NPM2.41%

TTM EBITDA %15.23%

Curr OPM6.81%

Last OPM4.24%

Curr NPM—

Last NPM—

Curr EPS₹5.91

Last EPS₹3.52

Balance sheet

Equity₹48.16 Cr

Reserve₹1.39K Cr

Total Debt₹591.34 Cr

D/E0.41x

Interest %62.47%

Curr Interest₹17.78 Cr

Price / range

Close₹644.90

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+2.41%

1W-1.22%

1M-9.86%

3M+24.06%

6M+24.50%

1Y+4.45%

2Y-18.98%

3Y+89.59%

5Y-48.52%

Diwali+14.51%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	417.34+33.1%	381.60	387.29	349	313.54	1,368.98
Other Income	0.23	1.92	4.42	0	0.49	5.89
Total Income	417.57+33.0%	383.52	391.71	349	314.03	1,374.87
Interest	16.36	20.23	27.06	22.45	20.83	94.24
Expenditure	-383.46-18.3%	-366.53	-382.84	-359.67	-324.11	-1,376.22
PBDT	0	0	0	0	0	0
EBITDA	76.88+121.2%	62.01	57.55	37.35	34.75	186.68
Depreciation	-26.64	-26.71	-26.04	-25.57	-24.49	-99.68
EBIT	50.24+389.7%	35.30	31.51	11.78	10.26	87
PBT	29.61+393.8%	16.99	9.73	-17.42	-10.08	-7.24
Tax	0	0	0	0	0	0
Equity	48.16	48.06	44.51	0	0	44.51
OPM	7.09	4.43	2.48	-4.99	-3.21	-0.53
Net Profit	29.61+393.8%	16.99	9.73	-17.42	-10.08	-7.24
NPM	7.09	4.43	2.48	-4.99	-3.21	-0.53
EPS	6.16+361.0%	3.67	2.23	-3.97	-2.36	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,368.98+6.6%	1,283.76-0.4%	1,288.92-10.7%	1,443.81+13.8%	1,268.34-21.6%	1,616.88
Other Income	5.89	9.14	5.37	22.14	18.76	28.41
Total Income	1,374.87+6.3%	1,292.90-0.1%	1,294.29-11.7%	1,465.95+13.9%	1,287.10-21.8%	1,645.29
Expenditure	-1,376.22-6.4%	-1,293.98+18.8%	-1,592.99-5.4%	-1,510.73-9.8%	-1,375.27+3.4%	-1,424.33
Interest	-94.24	-114.81	-105.97	-90.06	-75.27	-84.47
PBDT	0	0	0	0	0	0
EBITDA	186.68-8.4%	203.84+314.4%	-95.07-170.9%	134.04+66.8%	80.35-79.1%	385.33
Depreciation	-99.68	-99.25	-103.03	-110.90	-112.01	-108.31
EBIT	87-16.8%	104.59+152.8%	-198.10-956.1%	23.14+173.1%	-31.66-111.4%	277.02
PBT	-7.24-570.4%	-1.08+99.8%	-488.34-990.5%	-44.78+51.1%	-91.66-141.5%	220.96
Tax	0	0	-78.54	22.57	33.10	0
Equity	44.51	40.25	0	0	0	0
OPM (%)	-0.53	-0.08	-38.00	-3.00	-7.00	13.00
Net Profit	-7.24-570.4%	-1.08+99.8%	-566.88-2452.4%	-22.21+62.1%	-58.56-126.5%	220.96
NPM (%)	-0.53	-0.08	-44.00	-2.00	-5.00	13.00
EPS (Rs)	0	0+100.0%	-157.48-2452.4%	-6.17+62.1%	-16.29-123.7%	68.86
CEPS	0	0	-157.48	-6.17	-16.29	64.40

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	417.34+33.1%	381.60	387.29	349	313.54	1,368.98
Other Income	0.54	2.69	4.69	0	0.49	6.16
Total Income	417.88+33.1%	384.29	391.98	349	314.03	1,375.14
Interest	17.78	21.64	27.57	22.45	20.83	94.75
Expenditure	-384.92-18.8%	-367.98	-383.24	-359.68	-324.13	-1,376.66
PBDT	0	0	0	0	0	0
EBITDA	76.84+121.2%	61.97	57.66	37.34	34.73	186.75
Depreciation	-26.64	-26.71	-26.04	-25.57	-24.49	-99.68
EBIT	50.20+390.2%	35.26	31.62	11.77	10.24	87.07
PBT	28.46+381.8%	16.31	9.60	0	-10.10	-7.41
Tax	0	0	0	0	0	0
Equity	48.16	48.06	44.51	0	44.47	44.51
OPM	6.81	4.24	2.45	0.00	-3.22	-0.54
Net Profit	28.46+381.8%	16.31	9.60	-17.43	-10.10	-7.41
NPM	6.81	4.24	2.45	-4.99	-3.22	-0.54
EPS	0+100.0%	3.52	2.20	-3.98	-2.36	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,368.98+6.6%	1,283.76-0.4%	1,288.92-10.7%	1,443.81+13.8%	1,268.34-21.6%	1,616.88
Other Income	6.16	8.32	5.37	22.55	20.02	28.77
Total Income	1,375.14+6.4%	1,292.08-0.2%	1,294.29-11.7%	1,466.36+13.8%	1,288.36-21.7%	1,645.65
Expenditure	-1,376.66-6.6%	-1,291.54+18.9%	-1,592.54-5.4%	-1,511.17-9.8%	-1,375.97+3.4%	-1,424.15
Interest	-94.75	-114.81	-105.11	-90.06	-75.28	-84.48
PBDT	0	0	0	0	0	0
EBITDA	186.75-9.5%	206.28+316.7%	-95.18-171.1%	133.89+67.4%	79.97-79.3%	385.87
Depreciation	-99.68	-99.25	-103.33	-111.19	-112.32	-108.66
EBIT	87.07-18.6%	107.03+153.9%	-198.51-974.5%	22.70+170.2%	-32.35-111.7%	277.21
PBT	-7.41-1472.2%	0.54+100.1%	-488.42-990.0%	-44.81+50.8%	-91.10-141.1%	221.50
Tax	0	0	-78.54	22.57	32.81	-0.15
Equity	44.51	40.25	0	0	0	0
OPM (%)	-0.54	0.04	-37.74	-3.06	-7.07	13.46
Net Profit	-7.41-1472.2%	0.54+100.1%	-566.96-2449.3%	-22.24+61.8%	-58.29-126.3%	221.35
NPM (%)	-0.54	0.04	-43.80	-1.52	-4.52	13.45
EPS (Rs)	0-100.0%	0.14+100.1%	-157.62-2458.8%	-6.16+61.9%	-16.18-123.4%	69
CEPS	0	0.14	-157.62	-6.16	-16.18	64.52

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2021	Final Dividend	3	18 Aug 2021
2021	Interim Dividend	4	19 Nov 2020
2020	Final Dividend	2	28 Jul 2020
2019	Final Dividend	5	06 Aug 2019

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split